-
Gilead abandons CD47 monoclonal antibody, and no celebrity target has been successful so far
After about two years of downturn, the once popular innovative drug target CD47 has received bad news again. On February 7th, multinational pharmaceutical company (MNC) Gilead announced that it had s ...- qq95162547
- 2024-2-8 19:07
- 支持
- 反对
- 回复
- 收藏
-
Liantuo Biotechnology, which refuses to "sell themselves": both CEO and CFO have resigned and have sold celebrity products to earn price differences
Within two days, the CEO and CFO of Lian Biotech (LIAN. US) left one after another. On December 19th local time in the United States, Liantuo Biotechnology announced on its official website that its ... -
NVIDIA "Star" graphics card prices skyrocket in China: The game behind a graphics card
Recently, the US Department of Commerce announced the final rules for semiconductor export controls to China, and this news quickly spread to the consumer market. Many netizens have found that Nvidia ...